WAVEMAN · COMPANY

GMED · Globus Medical Inc

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

GMED

Name: GLOBUS MEDICAL INC (GMED) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

GLOBUS MEDICAL INC

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0001237831

CONGRESS · 1FORM 144 · 1☆ WATCH

INSIDER NET · 180D

-$4.2M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

336

13F, latest reported quarter

REVENUE GROWTH

+16.7%

XBRL, annual

NET MARGIN

18.3%

CONVERSIONS · 180D

codes C/M, not in net · $2.6M priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$4.2M over 180 days

-$2.2M over 90 days

below 73% of Medical Devices

CONGRESS

1 member bought in the last year

the lowest in Medical Devices

FUNDS

336 funds added or opened last quarter

more than 85% of Medical Devices

REVENUE

+16.7% year over year

more than 70% of Medical Devices

MARGIN

18.3% net margin

more than 92% of Medical Devices

BUYBACKS

$136.1M repurchased, FY to 2026-06-30

more than 66% of Medical Devices

SHORT

5.1% of shares outstanding short · 4.9 days to cover · settled 2026-07-31

more than 63% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

336 funds added or opened positions in the latest 13F quarter, of 600 holders.

1 member of Congress reported buying it this year.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +30.4%

+30.4%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $4.2M sold by insiders over 180 days, 336 funds added last quarter, 1 Congress member(s) bought in 12 months, $2.2M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, GLOBUS MEDICAL INC insiders sold a net $4.2M of stock across 54 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

ZARRILLI STEPHEN T

Director

SELL

2026-08-18

25,000.0

$2.2M

Davidar David D

Director

SELL

2026-06-05

25,000.0

$2.0M

Huller Kelly

EVP, GC, Corporate Secretary

SELL

2026-02-25

20,000.0

$1.9M

Huller Kelly

EVP, GC, Corporate Secretary

SELL

2026-02-12

10,000.0

$876.7K

Kline Kyle

Senior Vice President, CFO

SELL

2026-01-08

3,594.0

$363.4K

54 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 49 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

10,806,724.0 sh

$853.8M

Jupiter Topco LLC

8,200,423.0 sh

$647.9M

VANGUARD CAPITAL MANAGEMENT LLC

5,107,532.0 sh

$403.5M

VANGUARD PORTFOLIO MANAGEMENT LLC

4,994,385.0 sh

$394.6M

Invesco Ltd.

4,309,771.0 sh

$340.5M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

ZARRILLI STEPHEN T

FILED 2026-08-18

$2.2M

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Paradigm Select Fund

$7.1M POSITION · AS OF 2026-03-31

5.1%

GMO Small Cap Quality Fund

$28.0M POSITION · AS OF 2026-02-28

4.1%

Nationwide Geneva Small Cap Growth Fund

$42.1M POSITION · AS OF 2026-04-30

3.8%

Small-Company Stock Fund

$6.6M POSITION · AS OF 2026-03-31

3.3%

Geneva SMID Cap Growth Fund

$1.5M POSITION · AS OF 2026-02-28

3.2%

AlphaCentric Robotics and Automation Fund

$646.2K POSITION · AS OF 2026-03-31

3.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 3 registered trials, 2 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

2 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$2.9B	$2.5B	$1.6B	$1.0B
GROSS PROFIT	—	—	$1.0B	$759.1M
OPERATING INCOME	$479.8M	$166.0M	$133.1M	$228.0M
NET INCOME	$537.9M	$103.0M	$122.9M	$190.2M
EPS (DILUTED)	3.92	0.75	1.07	1.85
OPERATING CASH FLOW	$753.4M	$520.6M	$243.5M	$178.5M
CASH	$526.2M	$784.4M	—	—
BUYBACKS	$300.5M	$85.8M	$225.6M	$144.5M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE